John Pawelek, Who Explored the Causes of Metastasis, Dies at 79

The Yale School of Medicine cancer researcher doggedly pursued the question of how cancer spreads.

Written byMarcus A. Banks
| 2 min read
photograph of john pawalek in a navy blue suit and red tie

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

John Mason Pawelek, a dermatology and cancer researcher at the Yale School of Medicine, died on May 31 at age 79 of an apparent heart attack. Pawelek, a past president of the Pan American Society for Pigment Cell Research, had a longstanding interest in the biological factors that regulate skin pigmentation. In recent years, he became interested in understanding what causes the skin cancer melanoma to metastasize.

“Even though he was in his late 70s, John thought like a 19-year-old” in that he was always open to new ideas that cut against the grain, and was in no way beholden to current medical orthodoxies, says Greggory LaBerge, a medical geneticist at the University of Colorado School of Medicine who also directs the Denver Police Department’s Forensics and Evidence Division.

LaBerge collaborated frequently with Pawelek to test the provocative idea that many solid tumors spread throughout the body after immune cells ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • marcus a. banks

    Marcus is a science and health journalist based in New York City. He graduated from the Science Health and Environmental Reporting Program at New York University in 2019, and earned a master’s in Library and Information Science from Dominican University in 2002. He’s written for Slate, Undark, Spectrum, and Cancer Today.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies